Association of sodium-glucose cotransporter 2 inhibitor use with risk of osteoporotic fracture among older women: A nationwide, population-based cohort study.

MLA

Lee, Seunghyun, et al. “Association of Sodium-Glucose Cotransporter 2 Inhibitor Use with Risk of Osteoporotic Fracture among Older Women: A Nationwide, Population-Based Cohort Study.” Diabetes Research and Clinical Practice, vol. 213, July 2024, p. 111712. EBSCOhost, https://doi.org/10.1016/j.diabres.2024.111712.

APA

Lee, S., Yu, M. H., Hong, N., Kim, K. J., Kim, H. K., Rhee, Y., Lee, M., & Kim, K. M. (2024). Association of sodium-glucose cotransporter 2 inhibitor use with risk of osteoporotic fracture among older women: A nationwide, population-based cohort study. Diabetes Research and Clinical Practice, 213, 111712. https://doi.org/10.1016/j.diabres.2024.111712

Chicago

Lee, Seunghyun, Min Heui Yu, Namki Hong, Kyoung Jin Kim, Hae Kyung Kim, Yumie Rhee, Minyoung Lee, and Kyoung Min Kim. 2024. “Association of Sodium-Glucose Cotransporter 2 Inhibitor Use with Risk of Osteoporotic Fracture among Older Women: A Nationwide, Population-Based Cohort Study.” Diabetes Research and Clinical Practice 213 (July): 111712. doi:10.1016/j.diabres.2024.111712.